Parsortix Platform

In the Literature

Over 120 peer-reviewed journal articles from independent study centers around the globe

  • The Parsortix Platform is the most published marker-independent CTC enrichment Platform
  • The Parsortix Platform is utilized by 49 independent study centers and institutes globally
  • Published literature investigates 19 cancer types representing >65% of all solid tumors
  • Parsortix-enriched CTCs are suitable for a variety of multi-omic analysis techniques

Breast Cancer

Breast Cancer is the most frequently diagnosed cancer in women, with almost 2.3 million new cases diagnosed globally in 2022 and 8.2 million women living with the disease.
Breast cancer

Lung Cancer

Lung Cancer is the most common cancer globally with ~2.5 million new cases diagnosed each year and 3.2 million people living with this cancer.
Lung cancer

Prostate Cancer

Prostate Cancer is the second most common cancer in men, with 1 in 6 diagnosed in their lifetime. This equates to approximately 1.46 million men diagnosed globally each year, with...
Prostate cancer

Ovarian Cancer

Ovarian Cancer is the 8th most common cancer in women with 324,000 new cases diagnosed globally each year and 930,000 women living with this cancer.
Ovarian cancer

Glioblastoma

Glioblastoma (GBM) is the most common type of primary brain cancer in adults.
Glioblastoma

For Research Use Only. Not For Use in Diagnostic Procedures.

Request a meeting with